B. Amengual, J. Whitby, A. King, J. Cobo, and H. Bourhy, Evolution of European bat lyssaviruses., Journal of General Virology, vol.78, issue.9, pp.2319-2328, 1997.
DOI : 10.1099/0022-1317-78-9-2319

B. Archer and R. Dierks, Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine, Bull World Health Organ, vol.39, pp.407-417, 1968.

A. Ceballos, N. Vazquez-moron, S. Berciano, J. Nicolas, O. et al., Novel Lyssavirus in Bat, Spain, Emerging Infectious Diseases, vol.19, issue.5, pp.793-795, 2013.
DOI : 10.3201/eid1905.121071
URL : http://doi.org/10.3201/eid1905.121071

P. Atanasiu, M. Bahmanyar, M. Baltazard, J. Fox, K. Habel et al., Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons, Bull World Health Organ, vol.14, pp.593-611, 1956.

P. Atanasiu, D. Cannon, D. Dean, J. Fox, K. Habel et al., Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in nonexposed persons. 3, Bull World Health Organ, vol.25, pp.103-114, 1961.

P. Atanasiu, D. Dean, K. Habel, M. Kaplan, H. Koprowski et al., Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4, Bull World Health Organ, vol.36, pp.361-365, 1967.

V. Babes and M. Lepp, Recherches sur la vaccination antirabique, Ann Inst Pasteur, vol.3, pp.384-390, 1889.

H. Badrane, C. Bahloul, P. Perrin, and N. Tordo, Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity, Journal of Virology, vol.75, issue.7, pp.3268-3276, 2001.
DOI : 10.1128/JVI.75.7.3268-3276.2001

A. Bakker, W. Marissen, R. Kramer, A. Rice, W. Weldon et al., Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants, Journal of Virology, vol.79, issue.14, pp.9062-9068, 2005.
DOI : 10.1128/JVI.79.14.9062-9068.2005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1168753

A. Bakker, C. Python, C. Kissling, P. Pandya, W. Marissen et al., First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity, Vaccine, vol.26, issue.47, pp.5922-5927, 2008.
DOI : 10.1016/j.vaccine.2008.08.050

M. Baltazard and M. Bahmanyar, Field trials with rabies vaccine on persons bitten by rabid wolves, Bull World Health Organ, vol.13, pp.747-772, 1955.

L. Both, A. Banyard, C. Van-dolleweerd, D. Horton, J. Ma et al., Passive immunity in the prevention of rabies, The Lancet Infectious Diseases, vol.12, issue.5, pp.397-407, 2012.
DOI : 10.1016/S1473-3099(11)70340-1

H. Bourhy, B. Kissi, M. Lafon, D. Sacramento, and N. Tordo, Antigenic and molecular characterization of bat rabies virus in Europe, J Clin Microbiol, vol.30, pp.2419-2426, 1992.

H. Bourhy, B. Kissi, and N. Tordo, Molecular Diversity of the Lyssavirus Genus, Virology, vol.194, issue.1, pp.70-81, 1993.
DOI : 10.1006/viro.1993.1236

H. Bourhy, M. Goudal, A. Mailles, M. Sadkowska-todys, L. Dacheux et al., Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe, Euro Surveill, vol.14, 2009.

S. Brookes, G. Parsons, N. Johnson, L. Mcelhinney, and A. Fooks, Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses, Vaccine, vol.23, issue.32, pp.4101-4109, 2005.
DOI : 10.1016/j.vaccine.2005.03.037

V. Cabasso, J. Loofbourow, R. Roby, and W. Anuskiewicz, Rabies immune globulin of human origin: preparation and dosage determination in nonexposed volunteer subjects, Bull World Health Organ, vol.45, pp.303-315, 1971.

V. Cabasso, Properties of rabies immune globulin of human origin, Journal of Biological Standardization, vol.2, issue.1, pp.43-50, 1974.
DOI : 10.1016/S0092-1157(74)80007-7

V. Cabasso, M. Dobkin, R. Roby, and A. Hammar, Antibody response to a human diploid cell rabies vaccine, Appl Microbiol, vol.27, pp.553-561, 1974.

F. Cliquet, A. M. Sagne, and L. , Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody, Journal of Immunological Methods, vol.212, issue.1, pp.79-87, 1998.
DOI : 10.1016/S0022-1759(97)00212-3

D. Corti and A. Lanzavecchia, Broadly Neutralizing Antiviral Antibodies, Annual Review of Immunology, vol.31, issue.1, pp.705-742, 2013.
DOI : 10.1146/annurev-immunol-032712-095916

B. Dodet, The fight against rabies in Africa: From recognition to action, Vaccine, vol.27, issue.37, pp.5027-5032, 2009.
DOI : 10.1016/j.vaccine.2009.06.030
URL : https://hal.archives-ouvertes.fr/pasteur-01491973

H. Ertl, A. Fooks, A. Banyard, D. Horton, N. Johnson et al., Novel Vaccines to Human Rabies, PLoS Neglected Tropical Diseases, vol.26, issue.9, pp.515-1389, 2009.
DOI : 10.1371/journal.pntd.0000515
URL : http://doi.org/10.1371/journal.pntd.0000515

J. Goudsmit, W. Marissen, W. Weldon, M. Niezgoda, C. Hanlon et al., Comparison of an Anti???Rabies Human Monoclonal Antibody Combination with Human Polyclonal Anti???Rabies Immune Globulin, The Journal of Infectious Diseases, vol.193, issue.6, pp.796-801, 2006.
DOI : 10.1086/500470

S. Guindon and O. Gascuel, A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood, Systematic Biology, vol.52, issue.5, pp.696-704, 2003.
DOI : 10.1080/10635150390235520
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.110.5852

K. Habel, Antiserum in the prophylaxis of rabies, Bull World Health Organ, vol.10, pp.781-788, 1954.

K. Habel, Rabies Prophylaxis in Man, Public Health Reports (1896-1970), vol.72, issue.8, pp.667-673, 1957.
DOI : 10.2307/4589865

K. Hampson, L. Coudeville, T. Lembo, M. Sambo, A. Kieffer et al., Estimating the global burden of endemic canine rabies, PLoS Negl Trop Dis, vol.9, p.3709, 2015.

C. Hanlon, C. Demattos, C. Demattos, M. Niezgoda, D. Hooper et al., Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis, Vaccine, vol.19, issue.28-29, pp.3834-3842, 2001.
DOI : 10.1016/S0264-410X(01)00135-9

C. Hanlon, M. Niezgoda, P. Morrill, and C. Rupprecht, The incurable wound revisited: progress in human rabies prevention?, Vaccine, vol.19, issue.17-19, pp.2273-2279, 2001.
DOI : 10.1016/S0264-410X(00)00516-8

C. Hanlon, I. Kuzmin, J. Blanton, W. Weldon, J. Manangan et al., Efficacy of rabies biologics against new lyssaviruses from Eurasia, Virus Research, vol.111, issue.1, pp.44-54, 2005.
DOI : 10.1016/j.virusres.2005.03.009

K. Heckman and L. Pease, Gene splicing and mutagenesis by PCR-driven overlap extension, Nature Protocols, vol.2, issue.4, pp.924-932, 2007.
DOI : 10.1038/nprot.2007.132

P. Hooper, R. Lunt, A. Gould, H. Samaratunga, A. Hyatt et al., A new lyssavirus ??? fhe first endemic rabies-related virus recognized in Australia, Bulletin de l'Institut Pasteur, vol.95, issue.4, pp.209-218, 1997.
DOI : 10.1016/S0020-2452(97)83529-5

D. Horton, L. Mcelhinney, D. Marston, J. Wood, C. Russell et al., Quantifying Antigenic Relationships among the Lyssaviruses, Journal of Virology, vol.84, issue.22, pp.11841-11848, 2010.
DOI : 10.1128/JVI.01153-10

K. Katoh and D. Standley, MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability, Molecular Biology and Evolution, vol.30, issue.4, pp.772-780, 2013.
DOI : 10.1093/molbev/mst010

B. Kelley, Industrialization of mAb production technology: The bioprocessing industry at a crossroads, mAbs, vol.1, issue.5, pp.443-452, 2009.
DOI : 10.4161/mabs.1.5.9448

B. Kitasato, Ueber das Zustandekommender Diphterie-Immunitat und der Tetanus-Immunitat, Deutsche Medizinische Wochenschrift, 1890.

G. Kohler and C. Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, vol.3, issue.5517, pp.2453-2455, 1975.
DOI : 10.1038/256495a0

H. Koprowski, J. Van-der-scheer, and J. Black, Use of hyperimmune antirabies serum concentrates in experimental rabies, The American Journal of Medicine, vol.8, issue.4, pp.412-420, 1950.
DOI : 10.1016/0002-9343(50)90224-5

N. Kuzimina, I. Kuzmin, J. Ellison, and C. Rupprecht, Conservation of Binding Epitopes for Monoclonal Antibodies on the Rabies Virus Glycoprotein, Journal of Antivirals & Antiretrovirals, vol.05, issue.02, pp.37-43, 2013.
DOI : 10.4172/jaa.1000061

I. Kuzmin, A. Mayer, M. Niezgoda, W. Markotter, B. Agwanda et al., Shimoni bat virus, a new representative of the Lyssavirus genus, Virus Research, vol.149, issue.2, pp.197-210, 2010.
DOI : 10.1016/j.virusres.2010.01.018

M. Mallewa, A. Fooks, D. Banda, P. Chikungwa, L. Mankhambo et al., Rabies Encephalitis in Malaria-Endemic Area, Malawi, Africa, Emerging Infectious Diseases, vol.13, issue.1, pp.136-139, 2007.
DOI : 10.3201/eid1301.060810

S. Manning, C. Rupprecht, D. Fishbein, C. Hanlon, B. Lumlertdacha et al., Human rabies prevention?United States, 2008: recommendations of the Advisory Committee on Immunization Practices, MMWR Recomm Rep, vol.57, pp.1-28, 2008.

W. Marissen, R. Kramer, A. Rice, W. Weldon, M. Niezgoda et al., Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis, Journal of Virology, vol.79, issue.8, pp.4672-4678, 2005.
DOI : 10.1128/JVI.79.8.4672-4678.2005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1069557

D. Marston, D. Horton, C. Ngeleja, K. Hampson, L. Mcelhinney et al., Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet, Emerg Infect Dis, vol.18, pp.664-667, 2012.
DOI : 10.3201/eid1804.111553
URL : http://doi.org/10.3201/eid1804.111553

T. Nagarajan, W. Marissen, and C. Rupprecht, Monoclonal antibodies for the prevention of rabies: theory and clinical practice, Antibody Technology Journal, vol.4, pp.1-12, 2014.
DOI : 10.2147/ANTI.S33533

E. Sayers, T. Barrett, D. Benson, S. Bryant, K. Canese et al., Database resources of the National Center for Biotechnology Information, Database resources of the National Center for Biotechnology Information, pp.5-15, 2009.
DOI : 10.1093/nar/gkn741

F. Sievers and D. Higgins, Clustal Omega, Curr Protoc Bioinformatics, vol.27, issue.2, 2014.
DOI : 10.1002/0471250953.bi0313s48

R. Sikes, Human Rabies Immune Globulin: Progress Report, Public Health Reports (1896-1970), vol.84, issue.9, pp.797-801, 1969.
DOI : 10.2307/4593681

S. Sloan, C. Hanlon, W. Weldon, M. Niezgoda, J. Blanton et al., Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates, Vaccine, vol.25, issue.15, pp.2800-2810, 2007.
DOI : 10.1016/j.vaccine.2006.12.031

T. Tiller, E. Meffre, S. Yurasov, M. Tsuiji, M. Nussenzweig et al., Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning, Journal of Immunological Methods, vol.329, issue.1-2, pp.112-124, 2008.
DOI : 10.1016/j.jim.2007.09.017

E. Traggiai, S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu et al., An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus, Nature Medicine, vol.162, issue.8, pp.871-875, 2004.
DOI : 10.1128/JVI.77.19.10394-10403.2003

M. Warrell, A. Riddell, L. Yu, J. Phipps, L. Diggle et al., A Simplified 4-Site Economical Intradermal Post-Exposure Rabies Vaccine Regimen: A Randomised Controlled Comparison with Standard Methods, PLoS Neglected Tropical Diseases, vol.82, issue.4, p.224, 2008.
DOI : 10.1371/journal.pntd.0000224.s002

T. Wiktor, R. Lerner, and H. Koprowski, Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination, Bull World Health Organ, vol.45, pp.747-753, 1971.

E. Wright, N. Temperton, D. Marston, L. Mcelhinney, A. Fooks et al., Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison, Journal of General Virology, vol.89, issue.9, pp.2204-2213, 2008.
DOI : 10.1099/vir.0.2008/000349-0

E. Wright, S. Mcnabb, T. Goddard, D. Horton, T. Lembo et al., A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa, Vaccine, vol.27, issue.51, pp.7178-7186, 2009.
DOI : 10.1016/j.vaccine.2009.09.024

P. De, Benedictis et al A potent anti-rabies monoclonal antibody cocktail EMBO Molecular Medicine